The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity

被引:6
|
作者
de Mare, Arjan [1 ]
Bungener, Laura B. [1 ]
Regts, Joke [1 ]
de Vries-Idema, Jacqueline [1 ]
van der Zee, Ate G. J. [2 ]
Witschut, Jan [1 ]
Daemen, Toos [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Mol Virol Sect, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Dept Gynecol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
关键词
virosome; CTL; pre-existing immunity;
D O I
10.1016/j.vaccine.2008.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Protein antigens encapsulated in virosomes generated from influenza virus can induce antigen-specific cytotoxic T lymphocyte (CTL) responses. In the present study we determined, in a murine model system, whether pre-existing immunity against influenza virus hampers the induction of a CTL response. CTL induction was only slightly reduced by pre-injection of influenza virus-specific antibodies or pre-exposure to influenza virus. Both pre-treatments resulted in the same level of reduction, suggesting that virus-specific antibodies rather than T cell responses account for the reduction. Furthermore, a booster immunization enhanced CTL activation, indicating that virosome-specific immunity induced by a prime immunization does not hamper the booster effect. In conclusion, CTL induction against virosome-encapsulated protein antigens is not significantly inhibited by pre-existing humoral or cellular immunity against influenza virus. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2314 / 2321
页数:8
相关论文
共 50 条
  • [1] Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine
    Ben-Yedidia, T
    Arnon, R
    IMMUNOLOGY LETTERS, 1998, 64 (01) : 9 - 15
  • [2] Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines
    Sherritt, MA
    Gardner, J
    Elliott, SL
    Schmidt, C
    Purdie, D
    Deliyannis, G
    Heath, WR
    Suhrbier, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (02) : 671 - 677
  • [3] PRE-EXISTING IMMUNITY: A FITNESS INDEX FOR INFLUENZA VACCINATION
    Sinyakov, M.
    Avtalion, R.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (09): : 593 - 593
  • [4] Pre-existing immunity in human challenge studies of influenza transmission Reply
    Killingley, Ben
    Hayward, Andrew
    Enstone, Joanne E.
    Ferguson, Neil
    Oxford, John
    Nguyen-Van-Tam, Jonathan
    Booy, Robert
    LANCET INFECTIOUS DISEASES, 2012, 12 (10): : 744 - 745
  • [5] Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
    Roy, Sreeja
    Williams, Clare M.
    Wijesundara, Danushka K.
    Furuya, Yoichi
    VACCINES, 2020, 8 (04)
  • [6] Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses
    Le Sage, Valerie
    Jones, Jennifer E.
    Kormuth, Karen A.
    Fitzsimmons, William J.
    Nturibi, Eric
    Padovani, Gabriella H.
    Arevalo, Claudia P.
    French, Andrea J.
    Avery, Annika J.
    Manivanh, Richard
    McGrady, Elizabeth E.
    Bhagwat, Amar R.
    Lauring, Adam S.
    Hensley, Scott E.
    Lakdawala, Seema S.
    PLOS PATHOGENS, 2021, 17 (02)
  • [7] INFLUENCE OF PRE-EXISTING IMMUNITY UPON EFFECT OF SABIN VACCINE
    HIRAYAMA, M
    SAWADA, K
    JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1963, 16 (2-3): : 128 - &
  • [8] Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against Influenza
    Ng, Terry
    Flores-Malavet, Valeria
    Mansoor, Mishfak A. M.
    Arvelo, Andrea C.
    Dhume, Kunal
    Prokop, Emily
    McKinstry, K. Kai
    Strutt, Tara M.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (05): : 628 - 639
  • [9] Pre-existing heterologous T-cell immunity and neoantigen immunogenicity
    Leng, Qibin
    Tarbe, Marion
    Long, Qi
    Wang, Feng
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (03)
  • [10] Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes
    Arkema, A
    Huckriede, A
    Schoen, P
    Wilschut, J
    Daemen, T
    VACCINE, 2000, 18 (14) : 1327 - 1333